Metabolic & Weight

Tirzepatide Dosing & Reconstitution Calculator

Dual GIP and GLP-1 receptor agonist used for type 2 diabetes and weight loss.

TL;DR - Tirzepatide is a metabolic & weight peptide with a typical starting dose of 2.5 mg. For a 15 mg vial, add 1 mL bacteriostatic water to yield 15 mg/mL.
2.5 mg
Start Dose
15 mg
Vial
1 mL
BAC Water
15
mg/mL
2.5 mg draw on a 100-unit insulin syringe
010203040506070809010016.7 IUascendpeptide.org
Compare Similar
This Peptide
Tirzepatide
2.5 mg start
Retatrutide
0.5 mg start
Coming soon
Semaglutide
1 mg start
Coming soon
Track Tirzepatide in Protocol Tracker
Frequently Asked
How do I reconstitute Tirzepatide?
Add 1 mL of bacteriostatic water to a 15 mg vial, injecting slowly down the inside wall. Swirl gently; never shake. This yields a concentration of 15 mg/mL.
What is the recommended dose of Tirzepatide?
A typical research dose is 2.5 mg. Consult the ASCEND calculator for your specific vial concentration and draw volume.
How many doses are in a Tirzepatide vial?
A 15 mg vial reconstituted with 1 mL BAC water yields approximately 6 doses at 2.5 mg each.
How many IU is 2.5 mg of Tirzepatide on a syringe?
With a 15 mg vial reconstituted in 1 mL bacteriostatic water, the concentration is 15 mg/mL. For a 2.5 mg dose: Volume = 2.5 mg ÷ 15 mg/mL = 0.167 mL. Draw to the 16.7 line on a 100-unit insulin syringe. You can adjust these values in the ASCEND calculator for any vial size.
What does a Tirzepatide dosage calculator do?
A Tirzepatide dosage calculator converts your vial size and BAC water volume into an exact syringe draw in IU. Enter your vial strength (15 mg), reconstitution volume (1 mL), and target dose to get the precise line to draw on an insulin syringe.
What is the Tirzepatide reconstitution calculator formula?
Draw volume (mL) = Dose (mg) divided by Concentration (mg/mL). For a 15 mg vial with 1 mL BAC water: concentration = 15 mg/mL. For a 2.5 mg dose, the ASCEND calculator gives the exact IU line on your syringe instantly.
Peptide Intelligence
What is the half-life of Tirzepatide?
Tirzepatide has a half-life of approximately 5 days, enabling once-weekly subcutaneous injection. Its dual GIP/GLP-1 activity provides complementary mechanisms for glycemic control and weight reduction.
What injection sites are suitable for Tirzepatide?
Administer subcutaneously in the abdomen, thigh, or upper arm. Rotate injection sites with each dose to minimize local tissue reactions and lipohypertrophy over time.
How long before Tirzepatide effects become noticeable?
Appetite reduction is often reported within the first 1–2 weeks. Measurable weight changes are typically observed by week 4. Peak efficacy at maximum tolerated dose generally emerges after 3–6 months of titration.
Cite This Calculator